Busin M, Mönks T, Menzel C
Universitäts-Augenklinik Bonn.
Klin Monbl Augenheilkd. 1994 Jun;204(6):518-22. doi: 10.1055/s-2008-1045476.
BACKGROUND During the last two decades, hydroxyapatite has become popular as alloplastic material for bone replacement in orthopedic and dental surgery. We investigated prospectively the feasibility of hydroxyapatite spheres as replacement of enucleated eyes. PATIENTS AND METHODS Thirty-three consecutive patients entered a prospective study designed to evaluate the results obtained after either primary (n = 26) or secondary (n = 7) implantation of a hydroxyapatite sphere as replacement of the enucleated eyeball. Each patient was examined preoperatively, 1, 2, and 4 months after surgery, as well as every 6 months thereafter. At each examination time the motility of both coralline sphere and overlying cosmetic prosthesis was evaluated and the conjunctival sac was carefully examined at the slit-lamp. RESULTS The postoperative follow-up averaged 10.5 months for the primary implantations and 7.2 months for the secondary implantations. Two implants had to be removed because of infection unresponsive to antibiotic treatment. Defects in the conjunctiva overlying the implant necessitated wound revision in two cases. A buccal mucosal graft was performed in two additional ones. A temporary cosmetic prosthesis could be fitted in all but two of the remaining patients as early as 3 weeks after surgery. Motility of at least 3 mm in all directions could be obtained in 31 cases. CONCLUSION Our study demonstrated that satisfactory motility and good biocompatibility can be achieved, at least in the medium term, with implantation of coralline hydroxyapatite spheres.
背景 在过去二十年中,羟基磷灰石作为整形外科和牙科手术中用于骨替代的异体材料已变得很流行。我们前瞻性地研究了羟基磷灰石球替代摘除眼球的可行性。
患者与方法 连续33例患者进入一项前瞻性研究,该研究旨在评估首次(n = 26)或二次(n = 7)植入羟基磷灰石球替代摘除眼球后获得的结果。对每位患者在术前、术后1、2和4个月以及此后每6个月进行检查。在每次检查时,评估珊瑚球和其上的美容假体的活动度,并在裂隙灯下仔细检查结膜囊。
结果 首次植入术后随访平均为10.5个月,二次植入术后为7.2个月。有2个植入物因对抗生素治疗无反应的感染而不得不取出。植入物上方结膜的缺损在2例中需要进行伤口修复。另外2例进行了颊黏膜移植。除2例其余患者外,最早在术后3周即可安装临时美容假体。31例患者各个方向的活动度至少可达3mm。
结论 我们的研究表明,植入珊瑚羟基磷灰石球至少在中期可获得令人满意的活动度和良好的生物相容性。